Compare AVTR & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTR | INDV |
|---|---|---|
| Founded | 1904 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.4B |
| IPO Year | 2019 | 2014 |
| Metric | AVTR | INDV |
|---|---|---|
| Price | $9.19 | $36.13 |
| Analyst Decision | Hold | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $12.42 | N/A |
| AVG Volume (30 Days) | ★ 9.3M | 2.1M |
| Earning Date | 04-29-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | 0.06 | ★ 0.69 |
| Revenue | ★ $6,552,200,000.00 | $1,239,000,000.00 |
| Revenue This Year | $1.05 | N/A |
| Revenue Next Year | $1.86 | N/A |
| P/E Ratio | $152.92 | ★ $53.12 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $7.27 | $12.30 |
| 52 Week High | $15.93 | $41.00 |
| Indicator | AVTR | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 70.88 | 47.22 |
| Support Level | $8.90 | $35.36 |
| Resistance Level | $11.35 | $37.43 |
| Average True Range (ATR) | 0.35 | 1.08 |
| MACD | 0.15 | -0.41 |
| Stochastic Oscillator | 91.05 | 13.84 |
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).